News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
297,911 Results
Type
Article (16165)
Company Profile (67)
Press Release (281679)
Section
Business (95304)
Career Advice (849)
Deals (17922)
Drug Delivery (49)
Drug Development (36533)
Employer Resources (63)
FDA (8060)
Job Trends (6892)
News (158498)
Policy (14072)
Tag
Academia (1133)
Alliances (22359)
Alzheimer's disease (604)
Approvals (8065)
Artificial intelligence (127)
Bankruptcy (140)
Best Places to Work (5913)
Biotechnology (60)
Breast cancer (113)
Cancer (903)
Career advice (703)
Cell therapy (183)
Clinical research (29487)
Collaboration (394)
Compensation (69)
COVID-19 (1282)
C-suite (81)
Data (922)
Diabetes (98)
Diagnostics (3167)
Drug discovery (59)
Earnings (44966)
Events (36097)
Executive appointments (252)
FDA (8486)
Funding (330)
Gene therapy (128)
GLP-1 (300)
Government (1711)
Healthcare (9113)
Infectious disease (1342)
Inflammatory bowel disease (66)
Interviews (141)
IPO (9247)
Job creations (1292)
Job search strategy (594)
Layoffs (199)
Legal (3466)
Lung cancer (137)
Lymphoma (61)
Manufacturing (105)
Medical device (6063)
Medtech (6065)
Mergers & acquisitions (8910)
Metabolic disorders (269)
Neuroscience (821)
NextGen: Class of 2025 (2584)
Non-profit (1848)
Northern California (1074)
Obesity (157)
Opinion (123)
Patents (73)
People (24036)
Phase I (9569)
Phase II (12878)
Phase III (9853)
Pipeline (502)
Postmarket research (1038)
Preclinical (3758)
Radiopharmaceuticals (177)
Rare diseases (158)
Real estate (1883)
Regulatory (9647)
Research institute (1050)
Resumes & cover letters (154)
Series A (63)
Southern California (876)
Startups (1556)
United States (8834)
Vaccines (327)
Weight loss (105)
Date
Today (69)
Last 7 days (319)
Last 30 days (1375)
Last 365 days (19160)
2025 (1375)
2024 (19286)
2023 (21631)
2022 (27917)
2021 (29998)
2020 (27149)
2019 (20842)
2018 (16110)
2017 (15651)
2016 (14052)
2015 (16430)
2014 (11596)
2013 (8922)
2012 (9469)
2011 (10099)
2010 (8994)
Location
Africa (349)
Asia (18663)
Australia (3118)
California (2370)
Canada (1022)
China (197)
Colorado (94)
Connecticut (108)
Europe (42830)
Florida (323)
Georgia (77)
Illinois (197)
Indiana (98)
Japan (70)
Kansas (61)
Maryland (399)
Massachusetts (1770)
Michigan (126)
Minnesota (118)
New Jersey (729)
New York (673)
North Carolina (367)
Northern California (1074)
Ohio (68)
Pennsylvania (494)
South America (491)
Southern California (876)
Texas (293)
Washington State (231)
297,911 Results for "genzyme general".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legal
Novartis Loses Appeal to Bar Entresto Generic From U.S. Market
Novartis is seeking to prevent the entry of generics for its blockbuster heart failure drug Entresto, its top-selling asset that brought in more than $6 billion in net global sales last year.
December 5, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Next Generation Anti TIGIT Antibodies In Cancer Immunotherapy
January 29, 2025
·
1 min read
Legal
Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement
Sarepta has been hit with another patent infringement lawsuit, this time from Sanofi and its subsidiary Genzyme alleging that the biotech used protected technology related to AAV vectors.
August 1, 2024
·
2 min read
·
Tristan Manalac
Earnings
Teva Reports Strong Generics Demand in Q3, Expects Higher 2024 Revenue
Driven by copycat versions of Bristol Myers Squibb’s Revlimid and Novo Nordisk’s Victoza, Teva’s generics business was again a top-performer in the third quarter, with U.S. sales growing 30% and bringing in $1.1 billion in sales.
November 7, 2024
·
2 min read
·
Tristan Manalac
Patents
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug Entresto.
January 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Result of General Meeting
November 22, 2024
·
4 min read
Press Releases
Hemostemix is Up-Listing in the USA to Generate Liquidity
January 2, 2025
·
7 min read
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
Press Releases
Wedgewood Appoints Benjamin Daniels as General Counsel and Chief Compliance Officer
January 21, 2025
·
2 min read
Press Releases
Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis
January 9, 2025
·
13 min read
1 of 29,792
Next
